Biologic therapy in Sjögren's syndrome.

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Sjögren's syndrome (SS) is a chronic autoimmune disorder affecting exocrine glands, leading to dry eyes and mouth.
• Systemic complications can arise from extraglandular organ involvement.
• Current treatments focus on symptom management due to unclear pathogenesis and lack of effective therapies.

Purpose of the Study:

• To review and analyze the efficacy of biological agents in treating Sjögren's syndrome.
• To identify the molecular targets of these biological therapies.
• To explore improvements in treatment strategies for SS.

Main Methods:

• Systematic review of existing evidence on biological treatments for SS.
• Analysis of data on treatment efficacy and targeted pathways.
• Evaluation of potential improvements in therapeutic approaches.

Main Results:

• Biological agents show promise in treating Sjögren's syndrome by targeting specific molecular pathways.
• Evidence suggests varying efficacy depending on the agent and targeted mechanism.
• Further analysis can optimize the use of biological therapies.

Conclusions:

• Biological therapies represent a developing treatment avenue for Sjögren's syndrome.
• Understanding molecular targets is crucial for enhancing treatment efficacy.
• Improved strategies are needed to maximize the benefits of biological treatments for SS.